What are the symptoms of multiple myeloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Multiple Myeloma

Multiple myeloma presents with a constellation of symptoms primarily characterized by hypercalcemia, renal insufficiency, anemia, and bone lesions (CRAB features), which are the hallmark manifestations of end-organ damage caused by the proliferation of malignant plasma cells. 1, 2

Core Clinical Manifestations (CRAB Features)

Bone Disease

  • Bone pain: Most common symptom, particularly affecting the back, ribs, and pelvis 3
  • Lytic bone lesions: Present in nearly 80% of patients at diagnosis 4
  • Pathologic fractures: Especially vertebral compression fractures leading to height loss
  • Severe osteopenia: Can occur even without discrete lytic lesions

Hematologic Abnormalities

  • Anemia: Present in approximately 73% of patients 5
  • Weakness and fatigue: Common presenting symptoms due to anemia 4
  • Increased susceptibility to infections: Due to immune dysfunction

Renal Manifestations

  • Renal insufficiency: Present in about 25% of patients at diagnosis (creatinine ≥2 mg/dL) 4
  • Primary causes: "Myeloma kidney" (cast nephropathy) and hypercalcemia 4
  • Proteinuria: May be present due to light chain excretion

Metabolic Disturbances

  • Hypercalcemia: Can lead to:
    • Constipation
    • Confusion
    • Dehydration
    • Somnolence
    • Coma in severe cases 3

Neurological Manifestations

  • Spinal cord compression: Due to vertebral collapse or extramedullary plasmacytomas
  • Peripheral neuropathy: Can occur due to amyloid deposition or as a paraneoplastic phenomenon
  • Cranial nerve involvement: Particularly affecting II, V, VI, VII, and VIII cranial nerves 3

Less Common Presentations

  • Extramedullary plasmacytomas: Soft tissue masses of malignant plasma cells
  • Hyperviscosity syndrome: Visual disturbances, neurological symptoms, bleeding
  • Amyloidosis: Can present with:
    • Macroglossia (10% of cases)
    • Nephrotic syndrome
    • Congestive heart failure
    • Orthostatic hypotension
    • Sensorimotor peripheral neuropathy 4

Important Diagnostic Considerations

The diagnosis of symptomatic multiple myeloma requires:

  • ≥10% clonal plasma cells in bone marrow or a biopsy-proven plasmacytoma
  • Evidence of end-organ damage (CRAB criteria) attributable to the plasma cell disorder 1

CRAB Criteria Defined:

  • C: Hypercalcemia (serum calcium >11.5 mg/dL)
  • R: Renal insufficiency (serum creatinine >2 mg/dL or creatinine clearance <40 mL/min)
  • A: Anemia (hemoglobin <10 g/dL or ≥2 g/dL below lower limit of normal)
  • B: Bone lesions (lytic lesions, severe osteopenia, or pathologic fractures) 1, 2

Clinical Pitfalls

  1. Differential diagnosis: CRAB features are not exclusive to multiple myeloma; they can be seen in other conditions like diffuse large B-cell lymphoma 6

  2. Comorbidities in elderly patients: Several conditions can mimic myeloma manifestations:

    • Mild renal insufficiency due to diabetes or hypertension
    • Anemia due to nutritional deficiencies or chronic disease
    • Diffuse osteoporosis due to age or hormonal changes
    • Hypercalcemia due to hyperparathyroidism 1
  3. Distinguishing between MGUS, smoldering myeloma, and symptomatic myeloma: Requires careful evaluation of M-protein levels, bone marrow plasma cell percentage, and presence of end-organ damage 1

Multiple myeloma should be suspected in any patient over 60 years with unexplained anemia, renal failure, hypercalcemia, or bone pain, especially when accompanied by an elevated ESR, low albumin/globulin ratio, or unexplained back pain 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Multiple Myeloma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Neurologic sequelae of bone changes in multiple myeloma and its therapy].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.